Methods to modulate Rac1 import and to treat pulmonary fibrosis

US9416149B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9416149-B2
Application numberUS-201414262448-A
CountryUS
Kind codeB2
Filing dateApr 25, 2014
Priority dateApr 25, 2013
Publication dateAug 16, 2016
Grant dateAug 16, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides methods for treating fibrosis, as well as methods for modulating mitochondrial peroxide production in a cell, and methods for modulating the import of Rac1 into the mitochondria of a cell.

First claim

Opening claim text (preview).

What is claimed is: 1. A method to treat pulmonary fibrosis in an animal in need thereof comprising administering to the animal an effective amount of a compound of formula I, formula II or formula III: wherein: R 1 is a saturated or unsaturated (C 5 -C 20 )alkyl chain that optionally comprises one or more aryl rings in the chain and that is optionally substituted with one or more halo, trifluoromethyl, —OR a , —P(═O)(OR a ) 2 , or —NR b R c ; R 2 is a saturated or unsaturated (C 5 -C 20 )alkyl chain that optionally comprises one or more aryl rings in the chain and that is optionally substituted with one or more halo, trifluoromethyl, —OR a , —P(═O)(OR a ) 2 , or —NR b R c ; each R 3 , R 4 , R 5 , and R 6 is independently OH or (C 1 -C 6 )alkoxy; each R a is independently H, (C 1 -C 6 )alkyl, or aryl; and each R b and R c is independently H, (C 1 -C 6 )alkyl, or aryl; or R b and R c together with the nitrogen to which they are attached form a pyrrolidino, piperidino, morpholino, or thiomorpholino ring; wherein any aryl of R 1 , R 2 , R a , R b or R c is optionally substituted with one or more (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, NR d R e or S(O) 2 NR d R e , wherein each R d and R e is independently H or (C 1 -C 6 )alkyl; X is (C 1 -C 6 )alkyl; Y is (C 1 -C 6 )alkyl; R 7 is a saturated or unsaturated (C 1 -C 20 )alkyl chain that optionally comprises one or more aryl or heteroaryl rings in the chain wherein (C 1 -C 20 )alkyl is optionally substituted with one or more halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, aryl, heteroaryl, NR m R n or S(O) 2 NR p R q and wherein any aryl or heteroaryl is optionally substituted with one or more (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, NR a1 R b1 , or S(O) 2 NR c1 R d1 ; R 8 is H or a saturated or unsaturated (C 1 -C 20 )alkyl chain that optionally comprises one or more aryl or heteroaryl rings in the chain wherein (C 1 -C 20 )alkyl is optionally substituted with one or more halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, aryl, heteroaryl, NR m R n , or S(O) 2 NR p R q and wherein any aryl or heteroaryl is optionally substituted with one or more (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, NR a1 R b1 , or S(O) 2 NR c1 R d1 ; each R 9 , R 10 , R 11 , and R 12 is independently OH or (C 1 -C 6 )alkoxy; R 13 is a saturated or unsaturated (C 1 -C 20 )alkyl chain that optionally comprises one or more aryl or heteroaryl rings in the chain wherein (C 1 -C 20 )alkyl is optionally substituted with one or more halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, aryl, heteroaryl, NR m R n , or S(O) 2 NR p R q and wherein any aryl or heteroaryl is optionally substituted with one or more (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, NR a1 R b1 , aryl, heteroaryl, or S(O) 2 NR c1 R d1 ; R 14 is a saturated or unsaturated (C 1 -C 20 )alkyl chain that optionally comprises one or more aryl or heteroaryl rings in the chain wherein (C 1 -C 20 )alkyl is optionally substituted with one or more halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, aryl, heteroaryl, NR m R n , or S(O) 2 NR p R q and wherein any aryl or heteroaryl is optionally substituted with one or more (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, NR a1 R b1 , aryl, heteroaryl, or S(O) 2 NR c1 R d1 ; R 15 is a saturated or unsaturated (C 1 -C 20 )alkyl chain that optionally comprises one or more aryl or heteroaryl rings in the chain wherein (C 1 -C 20 )alkyl is optionally substituted with one or more halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, aryl, heteroaryl, NR m R n , or S(O) 2 NR p R q and wherein any aryl or heteroaryl is optionally substituted with one or more (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, NR a1 R b1 , or S(O) 2 NR c1 R d1 ; R 16 is H or a saturated or unsaturated (C 1 -C 20 )alkyl chain that optionally comprises one or more aryl or heteroaryl rings in the chain wherein (C 1 -C 20 )alkyl is optionally substituted with one or more halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, aryl, heteroaryl, NR m R n , or S(O) 2 NR p R q and wherein any aryl or heteroaryl is optionally substituted with one or more (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, NR a1 R b1 , or S(O) 2 NR c1 R d1 ; each R a1 and R b1 is independently H, (C 1 -C 6 )alkyl, or aryl; or R a1 and R b1 together with the nitrogen to which they are attached form a pyrrolidino, piperidino, morpholino, or thiomorpholino ring; each R c1 and R d1 is independently H, (C 1 -C 6 )alkyl, or aryl; or R c1 and R d1 together with the nitrogen to which they are attached form a pyrrolidino, piperidino, morpholino, or thiomorpholino ring; each R p and R q is independently H, (C 1 -C 6 )alkyl, or aryl; or R p and R q together with the nitrogen to which they are attached form a pyrrolidino, piperidino, morpholino, or thiomorpholino ring; each R p and R q is independently H, (C 1 -C 6 )alkyl, or aryl; or R p and R q together with the nitrogen to which they are attached form a pyrrolidino, piperidino, morpholino, or thiomorpholino ring; and wherein any aryl of R a1 , R b1 , R c1 , R d1 , R m , R n , R p or R q is optionally substituted with one or more (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, NR s R t , or S(O) 2 NR s R t wherein each R s and R t is independently H or (C 1 -C 6 )alkyl; or a pharmaceutically acceptable salt or prodrug thereof. 2. The method of claim 1 , comprising administering to the animal a compound of formula I: or a pharmaceutically acceptable salt or prodrug thereof. 3. The method of claim 1 , wherein R 1 is of the formula, wherein: n is 0, 1, or 2; and R g and R h together with the atoms to which they are attached form an aryl ring that is optionally substituted with one or more (e.g. 1, 2, 3, or 4) (C 1 -C 6 )alkyl, (C 1 -C 6 )alkoxy, (C 1 -C 6 )alkanoyl, (C 1 -C 6 )alkanoyloxy, (C 1 -C 6 )alkoxycarbonyl, halo, cyano, nitro, carboxy, trifluoromethyl, trifluoromethoxy, NR d R e , or S(O) 2 NR d R e , wherein each R d and R e is independently H or (C 1 -C 6 )alkyl. 4. The method of claim 1 , wherein R 1 is of the formula, wherein: n is 0, 1, 2, or 3; each bond designated by ----- is independently either present or is absent; and R b is phenyl or naphthyl and is optionally substituted with one or more carboxy or S(O) 2 NR d R

Assignees

Inventors

Classifications

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid · CPC title

  • having the two nitrogen atoms in positions 1 and 3 · CPC title

  • Five-membered rings · CPC title

  • Polyphosphonic acids · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9416149B2 cover?
The invention provides methods for treating fibrosis, as well as methods for modulating mitochondrial peroxide production in a cell, and methods for modulating the import of Rac1 into the mitochondria of a cell.
Who is the assignee on this patent?
Univ Iowa Res Found
What technology area does this patent fall under?
Primary CPC classification C07F9/65318. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Aug 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).